公司资料
Intelligent Bio Solutions 股价、新闻与催化剂
- 股票代码:
- INBS
- 交易所:
- NASDAQ
- 行业:
- MedTech
- 所在地:
- United States
股票表现
3.37 USD (+21.66%)
收盘价
最后更新: 2026年8月17日
6.08M USD
市值
股价为何变动
Following the latest company update, “Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification”, INBS closed up 21.7% at $3.37 on Aug 17, 2026. The move occurred in the trading session associated with this fda / regulatory update.
公司概览
业务概览
Intelligent Bio Solutions is a diagnostics company focused on rapid biosensor testing and point-of-care identification. Its business centers on using sensor technology to improve screening and clinical workflows.
所在地与行业分类
Intelligent Bio Solutions is headquartered in the United States and listed on NASDAQ. It sits in diagnostics and medical devices rather than biotechnology therapeutics.
商业模式特征
The company depends on product adoption, commercialization, and the ability to expand its testing platform across use cases. Investors usually watch device rollout, adoption, and revenue growth.
生物医药行业定位
Intelligent Bio Solutions is part of the diagnostics and biosensor infrastructure layer. It is not biotech, but it is relevant to the broader testing ecosystem.
未来催化剂
- Intelligent Bio Solutions’ catalysts are drug-testing and workplace-safety products, plus any commercial update that clarifies adoption. The story is about product utilization and recurring demand.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。